Stock Updates

How has Thermo Fisher Scientific, Inc.:(NYSE:TMO) performed recently?

Thermo Fisher Scientific, Inc. (NYSE: TMO) is a large market cap stock with a market cap of 60841.7. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 30.88, a forward P/E of 17.19 and EPS of 5.01. At a stock price of 152.53 (-1.31%) it has a dividend yield of 0.39%.

EPS growth for the last five years have been 15.00%, more recently this last year it has grown by 4.60%. The next year growth is going to be about 10.34% and more long-term 10.47% after five years. EPS growth quarter over quarter is 2.20%. Sales growth for the past five years have been 10.30% and sales growth quarter over quarter is 6.20%.

For performance, Thermo Fisher Scientific, Inc. the past week has seen a gain of -0.27%. For the last month performance for Thermo Fisher Scientific, Inc. is -1.55%. While the last quarter is 2.67% and half year, 19.34%. Finally for the year, performance is 27.59%.

The 52-week high for Thermo Fisher Scientific, Inc., is at -5.07%, and for the 52-week low it comes to a value of 30.67%. The 20-day simple moving average is -0.44% and 6.86% for the 200-day simple moving average.

Volatility for the week is at 1.03%, and for the month it is 1.12%. Thermo Fisher Scientific, Inc., has a target price of 172.06.

In terms of debt, long term debt/equity is 0.55, and for total debt/equity Thermo Fisher Scientific, Inc. has 0.67. The gross margin is 45.60%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1.1 and the quick ratio is 0.8.

Insider ownership is at 0.20%, with instituitional ownership at 89.40%. Thermo Fisher Scientific, Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 393.67. The shares float is 393.66, with the float short at 1.31%, with short ratio coming to 3.88.

In terms of returns, the return on assets see Thermo Fisher Scientific, Inc., get *TBA, with its returns on investment at 7.00%. Return on equity is *TBA. So will the investors see the target price of 172.06, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment